MGX Financials
Metagenomi, Inc. Common Stock - Financial statements & key metrics
Stock Price
$1.17
Market Cap
$44.42M
P/E Ratio
-0.5
EPS
$-2.39
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$52.30M
Gross Profit
-
Operating Income
-
Net Income
$-78.06M
EPS (Diluted)
$-2.36
Balance Sheet Highlights
Total Assets
$324.60M
Total Liabilities
$89.74M
Shareholders Equity
-
Cash & Equivalents
$27.39M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-109.07M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
-263.8%
Net Margin
-287.1%
ROE
-40.9%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is MGX revenue?
MGX's most recent quarterly revenue was $52.30M. Annual revenue can be calculated by summing the four most recent quarters.
Is MGX profitable?
MGX reported a loss of $78.06M in the most recent quarter. The net profit margin is -287.1%.
What is MGX market cap?
MGX has a market capitalization of $44.42M, making it a small-cap stock.
Does MGX have debt?
View MGX's balance sheet for debt information.
What is MGX cash flow?
Cash flow data is available in the full financial statements.